Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,288,480
-
Total 13F shares
-
26,309,917
-
Share change
-
+25,053,368
-
Total reported value
-
$214,342,391
-
Put/Call ratio
-
62%
-
Price per share
-
$8.15
-
Number of holders
-
152
-
Value change
-
+$204,195,190
-
Number of buys
-
142
-
Number of sells
-
1
Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) as of Q3 2024
As of 30 Sep 2024,
Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,309,917 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Anchorage Capital Group, L.L.C., Legal & General Group Plc, BlackRock, Inc., D. E. Shaw & Co., Inc., Opaleye Management Inc., TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
146
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.